dalteparin has been researched along with Endotoxemia in 5 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Endotoxemia: A condition characterized by the presence of ENDOTOXINS in the blood. On lysis, the outer cell wall of gram-negative bacteria enters the systemic circulation and initiates a pathophysiologic cascade of pro-inflammatory mediators.
| Excerpt | Relevance | Reference |
|---|---|---|
| "However, bleeding was more prominent in the fondaparinux group compared with the enoxaparin group at an equipotent dose for anti-Xa activity." | 1.38 | Enoxaparin and fondaparinux attenuates endothelial damage in endotoxemic rats. ( Aihara, K; Iba, T; Kayhanian, H; Ohike, T; Okamoto, K; Tajirika, T; Watanabe, S, 2012) |
| "The fibrinogen level was maintained at significantly better levels, and the elevation of alanine aminotransferase was significantly suppressed in enoxaparin group (P < 0." | 1.35 | Enoxaparin attenuates endothelial damage with less bleeding compared with unfractionated heparin in endotoxemic rats. ( Iba, T; Takayama, T, 2009) |
| " Herein, we studied the microhemodynamic and cellular mechanisms of this adverse effect of heparin on AT actions by the use of intravital microscopy and granulocyte culturing." | 1.31 | Adverse effect of heparin on antithrombin action during endotoxemia: microhemodynamic and cellular mechanisms. ( Dunzendorfer, S; Hoffmann, JN; Inthorn, D; Kaneider, NC; Laschke, MW; Menger, MD; Römisch, J; Schildberg, FW; Vollmar, B; Wiedermann, CJ, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoffmann, JN | 1 |
| Vollmar, B | 1 |
| Laschke, MW | 1 |
| Inthorn, D | 1 |
| Kaneider, NC | 1 |
| Dunzendorfer, S | 1 |
| Wiedermann, CJ | 1 |
| Römisch, J | 1 |
| Schildberg, FW | 1 |
| Menger, MD | 1 |
| Li, LF | 1 |
| Liu, YY | 1 |
| Lin, SW | 1 |
| Chang, CH | 1 |
| Chen, NH | 1 |
| Hung, CY | 1 |
| Lee, CS | 1 |
| Iba, T | 2 |
| Takayama, T | 1 |
| Okamoto, K | 1 |
| Ohike, T | 1 |
| Tajirika, T | 1 |
| Aihara, K | 1 |
| Watanabe, S | 1 |
| Kayhanian, H | 1 |
| Yeh, YC | 1 |
| Wang, MJ | 1 |
| Lin, CP | 1 |
| Fan, SZ | 1 |
| Tsai, JC | 1 |
| Sun, WZ | 1 |
| Ko, WJ | 1 |
5 other studies available for dalteparin and Endotoxemia
| Article | Year |
|---|---|
Adverse effect of heparin on antithrombin action during endotoxemia: microhemodynamic and cellular mechanisms.
Topics: Animals; Antithrombin III; Cell Communication; Chemotaxis, Leukocyte; Cricetinae; Drug Antagonism; E | 2002 |
Low-Molecular-Weight Heparin Reduces Ventilation-Induced Lung Injury through Hypoxia Inducible Factor-1α in a Murine Endotoxemia Model.
Topics: Animals; Anti-Inflammatory Agents; Chemokine CXCL2; Disease Models, Animal; Endotoxemia; Enoxaparin; | 2020 |
Enoxaparin attenuates endothelial damage with less bleeding compared with unfractionated heparin in endotoxemic rats.
Topics: Animals; Anticoagulants; CD13 Antigens; Endothelium; Endotoxemia; Enoxaparin; Fibrinogen; Hemorrhage | 2009 |
Enoxaparin and fondaparinux attenuates endothelial damage in endotoxemic rats.
Topics: Animals; Anticoagulants; Endothelium, Vascular; Endotoxemia; Enoxaparin; Factor Xa Inhibitors; Fonda | 2012 |
Enoxaparin sodium prevents intestinal microcirculatory dysfunction in endotoxemic rats.
Topics: Animals; Blood Flow Velocity; Endotoxemia; Enoxaparin; Hemodynamics; Intestines; Lipopolysaccharides | 2012 |